Overview


According to FutureWise analysis the market for anti-ageing drugs is expected to reach US$ 84.16 billion by 2031 at a CAGR of 7.42% over the forecast period of 2023-2031

Anti-aging drug is an emerging field of both medical science and applied medicine. It focuses on the underlying causes of aging and aims to reduce any age-related condition and extend the healthy lifespan of individuals with a youthful appearance. Anti-aging supplements are ingestible products promoted to diminish the effects of aging, including vitamin supplements, powders, oils, creams, etc. Anti-aging drugs are non-invasive medications that reduce aging signs, including fine lines, wrinkles, uneven skin tone, open pores, and facial volume loss. Skin aging is caused by both the factors such as intrinsic and extrinsic. And this can be divided into three main types – biological, environmental, and mechanical. These drugs are often offered by healthcare specialists, dermatologists, cosmetic surgeons, wellness centers, and spas.

Stem cells are the class of cells that can evolve into any cell in the body. They can divide and replicate indefinitely, making them a potential solution for reversing aging. Stem cells are a promising solution for reversing the visible signs of aging. These special cells can regenerate damaged tissues and improve overall cellular function, which may lead to a reduction in the appearance of wrinkles and other age-related changes. In addition, they possess anti-inflammatory and antiapoptotic properties by the secretion of paracrine-producing growth factors and cytokines on the administration site. Additionally, stem cells can modulate the immune system, which may help to improve overall health and well-being as we age.

FutureWise Market Research has published a report that provides an insightful analysis anti-ageing drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-ageing drugs market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Calico
  • Elysium Health Inc.
  • Unity Biotechnology
  • La Roche-Posay
  • Nu Skin
  • L'ORÉAL
  • Elysium
  • Nuritas
  • BIOTIME, INC.
  • DermaFix
  • Revision Optics
  • Frequency Therapeutics

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Anti-Ageing Drugs Market:

  • In April 2023, SkinCeuticals, a US-based advanced skincare company, launched a new corrective cream, A.G.E. Interrupter Advanced. The product enhances collagen matrix integrity. The formulation contains wild fruit flavonoids, glycyrrhetinic acid, and concentrated proxy lane (20% more than the original A.G.E. Interrupter). A.G.E. Interrupter Advanced goes above standard anti-aging products by addressing all stages of the glycation process, correcting current aging indicators, and defending against new and reoccurring harm caused by A.G.E. formation.
     
  • In July 2021, AbbVie Inc., a US-based pharmaceutical company involved in discovering and delivering innovative medicines, acquired Allergan plc for $63 billion. With this acquisition, it is expected to strengthen AbbVie as a well-diversified leader in important therapeutic categories. Allergan plc is a US-based pharmaceutical company manufacturing medical aesthetics drugs and medical devices, including anti-aging skin care products.

The rising influence of the lifestyle and fashion sectors has profoundly impacted the aging population's aspiration to maintain a youthful appearance. With trends in these industries emphasizing health, fitness, and youthful aesthetics, older individuals are increasingly motivated to seek anti-aging interventions. The presence of youthful appearance in social media and the promotion of age-defying products and approaches further fuel this desire. Therefore, the confluence of lifestyle and fashion with anti-aging aspirations is a significant driver for the growth of the anti-aging drugs market, further increasing the demand for innovative solutions to support youthful lifestyle among the elderly. Moreover, the growing prominence of topical medicinal agents and specialized compounds, such as antioxidants and cell regulators, is expected to propel the market's growth. These innovative topical treatments offer a non-invasive and user-friendly approach toward the signs of aging, resonating well with consumers seeking convenient yet practical solutions. Antioxidants play a vital role in neutralizing toxic free radicals that contribute to skin aging, while cell regulators promote skin rejuvenation at a cellular level. With increasing awareness about the benefits of these targeted interventions, the market is poised to witness boosted demand and adoption of anti-aging drugs market. However, developing a new targeted drug for the complex aging process is burdensome and demands substantial time and financial resources. This challenge is increased by the critical necessity of conducting extensive clinical trials to ascertain the drug's safety and effectiveness. It is capable of extending lifespan and enhancing overall quality of life while evading diverse side effects. These necessitate strict, long-term studies that might be resource-intensive and time-consuming, making the development of anti-aging drugs challenging for pharmaceutical companies and researchers. Therefore, hampering the growth of the anti-aging drugs market over the forecast period.
 

By Type

  • Serums and supplements
  • Antioxidants and enzymes
  • Stem cells and drugs

By Application

  • Skin and hair
  • Skeletal and muscles
  • Age-related disorders
  • Other

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the excellent living standards, large earning capacity, expanding influence of the fashion and lifestyle business among the population, infrastructure for conducting advanced research operations targeted at developing novel anti-aging products, growing prevalence of photoaging among people, and an increasing number of dermatologists in the U.S. is anticipated to boost the target market. Additionally, product innovations are a key trend gaining popularity in the anti-aging drugs market. Companies operating in the anti-aging drug market are adopting new innovative products to sustain their position in the market. For instance, in September 2022, La Roche-Posay(U.K.) launched a new effaclar salicylic acid acne treatment serum with added anti-aging benefits. Its new effaclas salicylic acid treatment serum is specifically formulated to target adult acne as the clinical signs differ from adolescents' development where the show-up and the type of acne occurs. Therefore, the above-mentioned factors are likely to propel the growth of the anti-aging drugs market during the forecast period in the area.

 
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Anti-Ageing Drugs Market By Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Anti-Ageing Drugs Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anti-Ageing Drugs Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Anti-Ageing Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Anti-Ageing Drugs Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Serums and supplements
        2. Antioxidants and enzymes
        3. Stem cells and drugs

  • 8.   Global Anti-Ageing Drugs Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Skin and hair
        2. Skeletal and muscles
        3. Age-related disorders
        4. Other

  • 9.   North America Anti-Ageing Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Anti-Ageing Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Anti-Ageing Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Anti-Ageing Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Calico
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Elysium Health Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Unity Biotechnology
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. La Roche-Posay
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Nu Skin
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. L'ORÉAL
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Elysium
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Nuritas.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. BIOTIME, INC.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.DermaFix
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Revision Optics
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Frequency Therapeutics
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11